Hancock Jaffe Announces One Year Follow-up Data on Eleventh VenoValve Patient albuquerqueexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from albuquerqueexpress.com Daily Mail and Mail on Sunday newspapers.
Hancock Jaffe Laboratories, Inc.: Hancock Jaffe Announces One Year Follow-up Data on Eleventh VenoValve Patient
IRVINE, CA / ACCESSWIRE /
, 2020 /
Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI)(NASDAQ:HJLIW), a developer of medical devices that restore cardiac and vascular health, announced today that the eleventh and final VenoValve patient in HJLI s first-in-human, clinical study has successfully reached the one-year milestone. Patient 11 s chronic venous insufficiency ( CVI ) has dramatically improved when compared to pre-surgery levels, with reflux (the backwards flow of blood) improving 70%, disease manifestations, as measured by a venous clinical severity scores ( VCSS ) improving 69%, and pain, as measured on a visual analog scale ( VAS ), improving 100%.